Quick10K

⚲

Manhattan Associates

Filings

10-Q	2021-03-31	Filed 2021-04-29
10-K	2020-12-31	Filed 2021-02-05
10-Q	2020-09-30	Filed 2020-11-02
10-Q	2020-06-30	Filed 2020-07-27
10-Q	2020-03-31	Filed 2020-05-01
10-K	2019-12-31	Filed 2020-02-10
10-Q	2019-09-30	Filed 2019-10-25
10-Q	2019-06-30	Filed 2019-07-25
10-Q	2019-03-31	Filed 2019-04-25
10-K	2018-12-31	Filed 2019-02-08
10-Q	2018-09-30	Filed 2018-10-25
10-Q	2018-06-30	Filed 2018-07-26
10-Q	2018-03-31	Filed 2018-04-27
10-K	2017-12-31	Filed 2018-02-09
10-Q	2017-09-30	Filed 2017-10-30
10-Q	2017-06-30	Filed 2017-07-24
10-Q	2017-03-31	Filed 2017-04-24
10-K	2016-12-31	Filed 2017-02-03
10-Q	2016-09-30	Filed 2016-10-21
10-Q	2016-06-30	Filed 2016-07-22
10-Q	2016-03-31	Filed 2016-04-22
10-K	2015-12-31	Filed 2016-02-05
10-Q	2015-09-30	Filed 2015-10-26
10-Q	2015-06-30	Filed 2015-07-28
10-Q	2015-03-31	Filed 2015-04-28
10-K	2014-12-31	Filed 2015-02-05
10-Q	2014-09-30	Filed 2014-10-29
10-Q	2014-06-30	Filed 2014-07-29
10-Q	2014-03-31	Filed 2014-04-29
10-K	2013-12-31	Filed 2014-02-06
10-Q	2013-09-30	Filed 2013-10-31
10-Q	2013-06-30	Filed 2013-07-31
10-Q	2013-03-31	Filed 2013-04-30
10-K	2012-12-31	Filed 2013-02-22
10-Q	2012-09-30	Filed 2012-10-31
10-Q	2012-06-30	Filed 2012-08-06
10-Q	2012-03-31	Filed 2012-05-04
10-K	2011-12-31	Filed 2012-02-23
10-Q	2011-09-30	Filed 2011-10-28
10-Q	2011-06-30	Filed 2011-07-29
10-Q	2011-03-31	Filed 2011-04-29
10-K	2010-12-31	Filed 2011-02-23
10-Q	2010-09-30	Filed 2010-10-29
10-Q	2010-06-30	Filed 2010-08-02
10-Q	2010-03-31	Filed 2010-04-30
10-K	2009-12-31	Filed 2010-02-19

Reports

8-K	2020-10-22
8-K	2020-07-23
8-K	2020-05-14
8-K	2020-04-21
8-K	2020-03-30
8-K	2020-02-04
8-K	2019-10-22
8-K	2019-07-23
8-K	2019-05-14
8-K	2019-04-23
8-K	2019-02-05
8-K	2018-10-23
8-K	2018-10-23
8-K	2018-07-24
8-K	2018-05-17
8-K	2018-04-24
8-K	2018-02-06

Manhattan Associates Financials

MANH Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	103	94	92	92	95	99	97	101	99	118	124	117	91	101	116	97	100	109	118	106	93	111	96	89	77	125	126	107	79	90	99	105	119	114
Accounts Receivable	53	57	56	57	64	73	62	60	68	68	71	67	87	88	87	83	83	92	97	84	93	99	100	84	96	97	92	85	99	93	100	107	100	108
Inventory
PP&E	14	14	70	14	14	14	63	15	14	14	64	14	15	16	68	19	20	21	75	21	21	20	66	17	16	15	63	16	15	15	64	13	15	21
Assets	268	263	260	258	262	276	262	265	269	287	298	291	289	305	318	300	300	323	338	303	294	316	297	287	285	326	315	307	292	291	307	360	372	380
Accounts Payable	9	8	8	6	8	8	10	7	7	8	12	8	10	10	12	10	9	10	11	10	12	10	12	11	13	15	14	15	21	14	18	17	17	21
Long-Term Debt
Liabilities	97	101	98	95	99	106	100	101	101	111	116	113	112	120	136	122	116	132	142	128	119	129	128	139	127	132	140	159	163	151	160	214	217	229
Stockholders' Equity	171	161	162	163	163	170	162	163	167	177	182	178	176	184	182	179	184	190	195	175	175	187	169	148	158	194	175	148	129	140	147	145	155	152


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	88	86	84	91	94	96	95	97	103	108	108	114	128	126	130	134	139	142	141	150	155	152	148	143	154	153	144	131	142	142	144	148	154	162
Cost of Revenue	27	28	27	38	39	41	43	43	44	45	49	48	55	54	59	58	59	58	46	65	63	62	48	62	62	63	59	58	59	61		67	72	74
Gross Profit	61	58	57	54	54	55	52	54	59	63	59	66	73	72	72	75	80	84	95	85	92	91	100	82	92	90	85	73	83	81		81	83	88
R&D	11	11	10	12	11	11	11	11	11	11	11	12	12	12	13	14	13	14	13	15	13	13	13	14	14	15	15	17	18	18	18	21	22	23
SG&A	22	20	21	23	22	20	20	21	20	20	21	23	25	22	28	23	24	25	26	25	24	21	26	24	23	22	25	26	27	24	27	30	31	28
Tax	6	5	6	6	9	8	7	6	10	12	8	11	12	13	10	14	16	16	13	16	20	20	16	13	18	19	18	6	9	9	7	7	7	9
Net Income	12	15	11	11	14	14	12	13	17	20	17	19	21	22	20	23	26	28	26	27	33	33	30	28	31	33	25	23	28	28	26	21	21	27


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		17	15	13	21	17	24	20	14	33	23	19		33	40	15	28	41	36	40	19	42	38	61	11	44	47	51		35		35	37	40
Cash Investing		-0	-1	0	-2	-3	-2	-2	-2	-2	-2	-2		-6	-1	-4	-1	-6	-2	-0	4	1	-1	-12	0	4	3	-15		-1		1	-3	-8
Cash Financing		-25	-14	-14	-14	-12	-23	-14	-12	-11	-14	-26		-15	-24	-29	-24	-25	-24	-53	-35	-25	-50	-57	-25	-0	-50	-56		-21		-30	-20	-36